RecruitingNCT07328035

Remission in Adults With Severe Asthma in Thailand


Sponsor

Thammasat University

Enrollment

230 participants

Start Date

Jan 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to determine the prevalence of remission among adults with severe asthma, as well as the factors associated with remission in Thailand. The main question the study aims to answer is: What is the prevalence of remission among adults with severe asthma in Thailand? Participants will complete questionnaires on asthma symptoms and undergo pulmonary function testing and a blood test once.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • severe asthma
  • age 18 years or older

Exclusion Criteria1

  • inability to perform spirometry or fractional exhaled nitric oxide (FeNO) test

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERGlobal Initiative for Asthma (GINA) and Asthma Control Test (ACT) questionnaires

GINA and ACT are questionnaires used to assess the level of asthma control.

DIAGNOSTIC_TESTSpirometry

Spirometry is a tool used to assess pulmonary function.

DIAGNOSTIC_TESTFractional exhaled nitric oxide (FeNO) test

FeNO is a tool used to assess eosinophilic airway inflammation and asthma remission.

DIAGNOSTIC_TESTBlood eosinophil count (BEC)

BEC is a tool used to assess eosinophilic inflammation and asthma remission.


Locations(1)

Narongkorn Saiphoklang

Pathum Thani, Thailand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07328035


Related Trials